Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals.

Safety of testosterone (T) administration in women.

July 2015

none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...

The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals

Scheele, F.
Hompes, P. G.A.
Gooren, L. J.G.
Spijkstra, J. J.
Spinder, T.

January 1991

Polycystic ovary disease generally is associated with elevated androgen levels and elevated luteiniz...

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men

Swerdloff, Ronald S
Dudley, Robert E

January 2020

BackgroundA novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short...

Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM):

July 2015

none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...

Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects.

July 2015

none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...

Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals

Meriggiola, Maria Cristina
Armillotta, Francesca
Costantino, Antonietta
Altieri, Paola
Saad, Farid
Kalhorn, Thomas
Perrone, Anna Myriam
Pelusi, Carlotta
Pelusi, Giuseppe
GHI, Tullio

January 2008

Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (F...

Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals.

July 2015

none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...

Metabolic effects of 6-month testosterone administration in female to male (FtM) transsexuals

July 2015

none6noneA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. MeriggiolaA. Costa...

Effect of different testosterone formulations on body weight, body composition and metabolism in Female to Male (FtM) transsexuals.

July 2015

none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...

High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM).

July 2015

none10noneA.M. Perrone; F. Armillotta; G. Formelli; P. Casadio; N.C.M. Salfi; L. Badiali De Giorgi; ...

Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons.

July 2015

none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...

Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration.

November 2018

none6noOBJECTIVE: To retrospectively evaluate and compare safety and efficacy of short and long-act...

A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen

February 2021

none9noBackground: While the effects of androgens on muscle are well described in hypogonadal men, l...

Cross-sex hormone administration changes pain in transsexual women and men.

July 2015

none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence

Wierckx, Katrien
Van Caenegem, Eva
Schreiner, Thomas
Haraldsen, Ira
Fisher, Alessandra
Toye, Kaatje
Kaufman, Jean
T'Sjoen, Guy

January 2014

Introduction. Data on the effects of cross-sex hormone therapy (CHT) are limited due to the low prev...

Safety of testosterone (T) administration in women.

July 2015

none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...

The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals

Scheele, F.
Hompes, P. G.A.
Gooren, L. J.G.
Spijkstra, J. J.
Spinder, T.

January 1991

Polycystic ovary disease generally is associated with elevated androgen levels and elevated luteiniz...

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men

Swerdloff, Ronald S
Dudley, Robert E

January 2020

BackgroundA novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short...

Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM):

July 2015

none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...

Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects.

July 2015

none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...

Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals

Meriggiola, Maria Cristina
Armillotta, Francesca
Costantino, Antonietta
Altieri, Paola
Saad, Farid
Kalhorn, Thomas
Perrone, Anna Myriam
Pelusi, Carlotta
Pelusi, Giuseppe
GHI, Tullio

January 2008

Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (F...

Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals.

July 2015

none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...

Metabolic effects of 6-month testosterone administration in female to male (FtM) transsexuals

July 2015

none6noneA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. MeriggiolaA. Costa...

Effect of different testosterone formulations on body weight, body composition and metabolism in Female to Male (FtM) transsexuals.

July 2015

none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...

High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM).

July 2015

none10noneA.M. Perrone; F. Armillotta; G. Formelli; P. Casadio; N.C.M. Salfi; L. Badiali De Giorgi; ...

Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons.

July 2015

none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...

Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration.

November 2018

none6noOBJECTIVE: To retrospectively evaluate and compare safety and efficacy of short and long-act...

A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen

February 2021

none9noBackground: While the effects of androgens on muscle are well described in hypogonadal men, l...

Cross-sex hormone administration changes pain in transsexual women and men.

July 2015

none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence

Wierckx, Katrien
Van Caenegem, Eva
Schreiner, Thomas
Haraldsen, Ira
Fisher, Alessandra
Toye, Kaatje
Kaufman, Jean
T'Sjoen, Guy

January 2014

Introduction. Data on the effects of cross-sex hormone therapy (CHT) are limited due to the low prev...

Safety of testosterone (T) administration in women.

July 2015

none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...

The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals

Scheele, F.
Hompes, P. G.A.
Gooren, L. J.G.
Spijkstra, J. J.
Spinder, T.

January 1991

Polycystic ovary disease generally is associated with elevated androgen levels and elevated luteiniz...

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men

Swerdloff, Ronald S
Dudley, Robert E

January 2020

BackgroundA novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short...

Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals.

Abstract

Extracted data

Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals.

Abstract

Extracted data

Related items

Related items